(Q77879644)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11932876%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Role of initial NSAID choice and patient risk factors in the prevention of NSAID gastropathy: a decision analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11932876%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

A Mark Fendrick

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11932876%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Rajesh R Bandekar

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11932876%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Michael E Chernew

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11932876%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

James M Scheiman

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11932876%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 February 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11932876%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

published in

Arthritis and Rheumatism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11932876%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11932876%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11932876%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

36-43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11932876%20AND%20SRC:MED&resulttype=core&format=json

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

Excess costs from gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

FDA Arthritis Advisory Committee meeting: postmarketing surveillance of nonsteroidal antiinflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

Preventing NSAID-induced gastrointestinal toxicity. Economic considerations, methodological problems and results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

Economic evaluation of gastric ulcer prophylaxis in patients with arthritis receiving non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

The cost effectiveness of diclofenac plus misoprostol compared with diclofenac monotherapy in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

The cost-effectiveness of misoprostol in preventing serious gastrointestinal events associated with the use of nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

Misoprostol for the treatment of peptic ulcer and antiinflammatory-drug-induced gastroduodenal ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

Analysis of the costs of NSAID-associated gastropathy. Experience in a US health maintenance organisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

NSAIDs, gastrointestinal injury, and cytoprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

Markov models in medical decision making: a practical guide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

Decision analytic modeling and NSAID gastropathy could we be more sensitive?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

Nizatidine prevents peptic ulceration in high-risk patients taking nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

COX-1-sparing NSAIDs--is the enthusiasm justified?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART1.10159

21 January 2018

Identifiers

DOI

10.1002/ART1.10159

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11932876%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference